Both in Pharmaceuticals
Artelo Biosciences vs Kairos Pharma
Over the past year ARTL returned −97.3% and KAPA returned −93.3%; their daily moves had a correlation of -0.35.
ARTL −97.3% KAPA −93.3%Growth of $1, one year, split-adjusted
| Metric | ARTL | KAPA |
|---|---|---|
| Price | $2.22 | $0.5300 |
| Market cap | $1.2M | $1.8M |
| Today | −3.90% | −1.87% |
| 1 month | −42.0% | −66.0% |
| 6 months | −92.7% | −86.6% |
| Year to date | −93.3% | −89.3% |
| 1 year | −97.7% | −93.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.2M | $2.6M |
| Dividend yield | — | — |
| Volatility (60d) | 650.2% | 580.2% |
| Short % of float | 0.8% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).